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Abstract Sendai virus (SeV) is an enveloped virus with a
negative sense genome RNA of about 15.3 kb. We previously
established a system to recover an infectious virus entirely from
SeV cDNA and illustrated the feasibility of using SeV as a novel
expression vector. Here, we have attempted to insert a series of
foreign genes into SeV of different lengths to learn how far SeV
can accommodate extra genes and how the length of inserted
genes affects viral replication in cells cultured in vitro and in the
natural host, mice. We show that a gene up to 3.2 kb can be
inserted and efficiently expressed and that the replication speed
as well as the final virus titers in cell culture are proportionally
reduced as the inserted gene length increases. In vivo, such a size-
dependent effect was not very clear but a remarkably attenuated
replication and pathogenicity were generally seen. Our data
further confirmed reinforcement of foreign gene expression in
vitro from the V(3) version of SeV in which the accessory V gene
had been knocked out. Based on these results, we discuss the
utility of SeV vector in terms of both efficiency and safety.
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1. Introduction
Sendai virus (SeV), a member of the genus Respirovirus in
the family Paramyxoviridae, is an enveloped virus with a non-
segmented negative sense genome RNA of about 15.3 kb. In
the genome RNA of negative sense (3)RNA, the extracis-
tronic 3P leader and 5P trailer regions, which are about 50
nucleotides in length and contain cis-acting elements essential
for replication, £ank six genes, which encode the nucleocapsid
(N) protein, phospho (P) protein, matrix (M) protein, fusion
(F) protein, hemagglutinin-neuraminidase (HN) and large (L)
protein in this order from the 3P terminus. The genome RNA
is tightly associated with the structural subunits, N proteins,
and further complexed with the RNA polymerase comprising
the L and P proteins [1], forming a helical ribonucleoprotein
complex, (3)RNP. L represents the catalytic chain and P is an
essential modulator in RNA synthesis. The (3)RNP complex,
not the naked RNA, is functional as the template for both
transcription and replication. There is only a single promoter
at the 3P end for the polymerase. By recognizing the end (E)
(termination/polyadenylation) and start (S) signals present at
each gene boundary, the polymerase gives rise to each mRNA
(reviewed in [2,3]). After translation of these mRNAs and
accumulation of the translation products, genome replication
begins. Here, the same polymerase copies the same RNP tem-
plate, but now ignores the successive stop signals and reads
through each gene boundary to generate a full length antige-
nomic (+)RNP. Association of the newly synthesized N sub-
units with the nascent RNA chain is a precondition for read-
through. Thus, encapsidation and replication are tightly
coupled and synchronized with each other. The (+)RNP, in
turn, serves as the template for the synthesis of (3)RNP. The
viral components meet at the plasma membrane and the ma-
ture virions are formed and released by budding.
We have established a system to recover SeV entirely from
cDNA with a remarkably high e⁄ciency [4]. Thus, the SeV
genome can be changed at will and the outcomes can be
evaluated in the context of not only viral replication in culture
cells but also viral pathogenesis in the natural host, mice ([5^
8], for a review see [3]). The technology has also opened the
possibility to use SeV as a novel expression vector ([9^11], for
a review see [3]). SeV is only moderately pathogenic for cells
in culture, reaches an extremely high copy number in cells and
has a broad cellular host range. Moreover, the V(3) SeV
whose V protein expression was knocked out reached even a
higher copy number than the standard SeV [5,6] and is there-
fore extremely useful to achieve a high level of foreign gene
expression in cells of interest. For instance, the expression
level of gp120 envelope glycoprotein of human immunode¢-
ciency virus type 1 (HIV-1) from the V(3) version in certain
cell lines appeared to be the highest available in mammalian
cells [10]. Thus, recombinant SeV technology is greatly facil-
itating biochemical and structural studies of medically impor-
tant proteins ([12], for a review see [3]). The SeV V protein
itself is an accessory protein. Although perfectly competent
for tissue culture replication as described above, the V knock
out SeV was found to be rapidly cleared from the mouse lung
by some innate immunity recruited early in infection and se-
verely impaired in virulence for mice, suggesting that the V
protein encodes a luxury function required for in vivo patho-
genesis ([5,6], for a review, see [3]).
In this study, we attempted to insert into SeV and express
from SeV foreign genes of various lengths to know how far
SeV can tolerate additional length and how viral replication
both in vitro and in vivo is a¡ected by the length. The results
indicated that SeV can stably express genes up to 3.2 kb in
length. The viral replication in cell culture was retarded con-
versely as the inserted gene length was increased. Viral multi-
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plication and pathogenicity in mice were also attenuated. The
results con¢rmed the superiority of the V(3) version for a
higher expression as well as convenience of the cassette-like
insertion developed previously [9].
2. Materials and methods
2.1. Insertion of foreign genes into SeV cDNA plasmid
Fig. 1 illustrates the basic strategies for insertion of a foreign gene
into the SeV genome. The SeV genome length appears to have to be a
multiple of six nucleotides for e⁄cient replication [13]. Without vio-
lating this ‘rule of six’, the SeV cDNA plasmid, named pSeV18b(+),
was constructed, which contains an 18 nucleotide insert with a unique
NotI site just upstream of the N open reading frame (ORF) within the
3P proximal N gene (in genomic negative sense) and generates anti-
genomic positive sense RNA [9] (Fig. 1). This construct allowed for a
straightforward insertion of a gene PCR-ampli¢ed with NotI-tagged
primers (again without violating the rule of six) in a cassette-like
fashion [9]. SeV speci¢c transcription termination (E) and restart (S)
signals connected with a trinucleotide intergenic sequence were in-
cluded in the antisense primer for the PCR reaction. The recovered
virus was named SeV18b+. Using the synthetic E and S signals, the
inserted gene expression is terminated and the downstream neighbor
N gene expression is initiated, respectively (Fig. 1). The transcription
start of the inserted gene itself is driven by the S signal originally used
for the N gene start of the parental SeV. In SeV transcription, restart
at each gene boundary is e⁄cient but not perfect, causing polar at-
tenuation of gene expression toward the 5P end (reviewed in [2]). All
insertions were therefore made in the upstream region of the 3P prox-
imal N gene ORF. Not only the standard SeV but also the V(3)
version were used for a higher level of expression [10]. The foreign
genes, which we attempted to insert, included those encoding stromal
cell-derived factor 1K (SDF-1K) [11], green £uorescent protein of
Aequore victoria (GFP), HIV-1 gp120 [10], ¢re£y luciferase (luci) [9],
L-glucuronidase (L-glu) and lacZ encoding L-galactosidase (L-gal).
The sizes of these foreign genes ranged from 0.4 to 3.2 kb (Table
1). L-Glu is relevant to mucopolysaccharidosis VII.
2.2. Transfection of cDNAs and infectious virus recovery
Viruses were recovered from cDNAs essentially according to the
previously described procedure [4]. Brie£y, 1.2U107 LLCMK2 cells,
a monkey kidney line, were infected with a recombinant vaccinia virus
(VV), vTF7-3, expressing T7 polymerase [14] at a multiplicity of two
plaque forming units (PFU) per cell. Then, 60 Wg of a SeV plasmid
with a given insert and the plasmids encoding trans-acting proteins,
pGEM-N (24 Wg), pGEM-P (12 Wg) and pGEM-L (24 Wg), were trans-
fected simultaneously with aid of the lipofection reagent DOTAP
(Boehringer-Mannheim). The cells were maintained in serum free min-
imal essential medium in the presence of 40 Wg/ml cytosine arabino-
furanoside and 100 Wg/ml rifampicin to minimize VV cytopathogenic-
Fig. 1. Insertion of a foreign gene into the SeV cDNA plasmid. The SeV cDNA plasmid, named pSeV18b(+), contains an 18 nucleotide insert
with a unique NotI site just upstream of the N ORF within the 3P proximal N gene and generates antigenomic positive sense RNA. This con-
struct allowed for a straightforward insertion of a gene PCR-ampli¢ed with NotI-tagged primers in a cassette-like fashion. SeV speci¢c tran-
scription termination (E) and restart (S) signals connected with a trinucleotide intergenic sequence were included in the antisense primer for the
PCR reaction. Not only the standard SeV but also the V(3) version were used (see the text).
Table 1
Sizes of inserted genes and the ¢nal titers of recovered recombinant
SeVs after propagation in embryonated chicken eggs
Inserted gene Size (kb) Titer (109 PFU/ml)
SeV18b V(3) SeV18b
18b 7.93 4.33
SDF-1K 0.4 9.74 4.79
GFP 0.7 1.14 4.47
HIV gp120 1.6 0.39 2.45
Luci 1.7 3.03 ^
L-Glu 2.1 0.74 ^
L-Gal 3.2 2.79 1.62
^, not done.
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ity and thereby maximize the recovery rate [4]. 40 h after transfection,
cells were harvested, disrupted by three cycles of freezing and thawing
and injected into the allantoic cavity of 10 days old embryonated
chicken eggs. After 3 days of incubation, the allantoic £uid was har-
vested. The titers of recovered viruses were expressed in hemaggluti-
nation units (HAU) and PFU per ml as described previously [4]. The
allantoic £uid of the eggs contained 108^109 PFU per ml of the re-
covered virus along with the helper VV in an amount of 103^104 PFU
per ml. The latter was completely eliminated by the second propaga-
tion in eggs at a dilution of 1036 [4]. The second passages were used as
the stock viruses for all the experiments.
2.3. Infection and pathogenicity studies
CV1 cells, a monkey kidney cell line, were used for studies of tissue
culture replication as described previously [5,6]. For in vivo replica-
tion and pathogenicity studies, speci¢c pathogen free, 3 weeks old
mice of the strain ICR/Crj (CD-1) (Charles River, Tokyo, Japan)
were used. Virus titers in the lungs were determined by cell infectious
units per lung and pathogenicity by consolidation scores of the lungs
and disturbance of body weight gain as described [5,6,8].
3. Results
3.1. Recovery of recombinant viruses
We inserted various foreign genes into the cDNAs encoding
the standard or V(3) SeV antigenome RNA or both and
attempted virus recovery according to the protocol described
in Section 2 and illustrated in Fig. 2. The NotI-based cassette
insertion has been generally convenient as no NotI site was
present in the genes to be inserted except lacZ. One NotI site
was present in the lacZ. This one was disrupted prior to PCR
ampli¢cation. Virus recovery was successful in most attempts.
However, there were some but rare unsuccessful cases despite
repeated trials. The reason for this was initially unclear but
careful inspection of the sequences to be inserted revealed that
these genes contained a region resembling the SeV E signal
(AUUCUUUUU). Most likely, such an E-like sequence in-
duced premature transcription termination, eventually leading
to failure of virus recovery. In these cases, E-like sequences
were disrupted and viruses were successfully recovered. The
¢nal titers of recovered recombinants after propagation in
embryonated chicken eggs are shown in Table 1.
We previously showed that the recombinant SeV18b+ with
an 18 nucleotide insert and the original wild-type SeV were
very similar in replication in cultured cells and multiplication
and pathogenicity in mice. SeV18b+ but not wild-type cDNA
was the starting material for insertion of foreign genes (see
Section 2). Thus, we used SeV18b+ or its V(3) version as a
control for all subsequent experiments.
Fig. 2 compares replication kinetics of various recombinant
viruses derived from the standard V(+) version under the
conditions of both a single round and multiple rounds of
replication in CV1 cells. Replication kinetics were found to
become slower as the inserted gene became longer. The peak
titers also became lower, but the reductions were only by
several folds at most under single cycle growth conditions
(cf. L-gal and control in Fig. 2). As expected, under multiple
cycle conditions which involved numerous rounds of replica-
tion, more profound di¡erences were seen between the control
and each recombinant except SeV/SDF-1K in replication ki-
netics and the ¢nal yield (Fig. 2). Thus, size-dependent repli-
cation retardation and titer reduction were both quite clear.
These results suggest that the products from inserted genes are
so far neutral without giving a particular advantage or dis-
advantage to the viral replication capability and argues for
that the speed of genome replication is inversely correlated
simply with the length of inserted genes. A very similar ten-
dency was found with recombinant viruses based upon the
V(3) version (Fig. 2). If a pair of recombinant viruses ex-
pressing a given gene were compared, the V(3) version always
displayed a faster replication than the V(+) version, con¢rm-
ing our previous results [5,6,10].
3.2. Expression of foreign genes from recombinant viruses and
its reinforcement with the V(3) version
Fig. 3A illustrates the expression of GFP and L-gal from
the respective V(3) recombinant viruses in CV1 cells. Their
Fig. 2. Replication of various recombinant SeVs in CV1 cells. Growth kinetics of V(+) (A) and V(3) (B) recombinant viruses under the condi-
tions of both single round (multiplicity of infection (moi) is 10 PFU/cell) and multiple rounds (moi 0.01 PFU/cell) of replication are compared.
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expression from the V(3) version was already extensive at 24
h post-infection under single cycle growth conditions. Rein-
forced expression by the V(3) version was con¢rmed by com-
paring to intracellular and extracellular L-gal activities ex-
pressed from the standard V(+) and V(3) versions (Fig.
3B). Similar vigorous expression from the V(3) SeV in CV1
and other cell lines as well as primary cells of human and
avian origins were previously demonstrated for SDF-1K [11],
luci [9] and HIV-1 gp120 [10]. These results clearly argue for
the utility of SeV, particularly its V(3) version, as a novel
expression vector to produce foreign proteins of interest in
cultured cells of interest.
3.3. In vivo pathogenicity of recombinant viruses
Fig. 4A shows the replication and pathogenicity of various
V(+) recombinant viruses. The virus expressing the shortest
gene, SDF-1K, appears to have retained a certain degree of
pathogenicity, as body weight gain was greatly disturbed for
two of the three mice. Consistent with this, the virus repli-
cated remarkably well and produced high consolidation scores
in the lungs. In contrast, the viruses expressing GFP and
others longer than the GFP were greatly attenuated, allowing
a body weight gain almost comparable to those of the mock-
infected mice. This attenuation appeared to be paralleled with
lower consolidation scores and less e⁄cient viral replication in
the lungs, compared with the control infection. Thus, the ex-
tra genes also appeared to a¡ect in vivo viral replication in a
length-dependent manner. However, while insertion of a rel-
atively short gene, GFP, resulted in a reduction of the virus
titer in the lungs by as much as 100-fold, no further attenu-
ation of replication was seen with longer genes, gp120, luci, L-
glu and L-gal. Therefore, in vivo virus growth was not so
¢nely graded by the inserted gene length as in vitro growth.
These results suggest the presence of much more complex
conditions in vivo where replication would not only be limited
by extra gene length but also a¡ected somehow by the bio-
logical nature of the gene products and/or di¡erences in host
response to the products. The V(3) SeV was previously found
to be greatly attenuated in multiplication and pathogenicity in
vivo [5,6]. This was con¢rmed here (Fig. 4B). The V protein
appeared to encode a luxury function for the virus to cope
with some early host response [5,6]. The V(3) virus is thus
Fig. 3. Expression of foreign genes from recombinant viruses and its reinforcement with the V(3) version. (A) Expression of GFP and L-gal
from the respective V(3) recombinant viruses in CV1 cells at 24 h post-infection at a moi of 0.1 PFU/cell. (B) Comparison of intracellular and
extracellular L-gal activities expressed from the standard V(+) and V(3) versions at various times post-infection. Virus titers at each time point
are shown by HAU.
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characterized by an apparently normal rapid replication at the
initial day of infection followed by a rapid clearance from the
body (Fig. 4B). Its overall in vivo replication pattern was
simpler than that of the V(+) counterpart which was featured
by maintenance of high virus titers for a long period (Fig.
4A). It may be interesting to note that extra gene length-de-
pendent growth restriction has been seen more clearly in V(3)
infections than in V(+) infections (cf. Fig. 4A and B).
4. Discussion
We have previously shown that foreign genes, such as those
Fig. 4. Replication and pathogenicity of various recombinant viruses in mice. Virus titers in the lungs were determined by cell infectious units
per lung and pathogenicity by consolidation scores of the lungs and disturbance of body weight gain as described [5,6]. O, mock-infected.
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encoding SDF-1K, SDF-1L, luci and HIV-1 gp120, can be
inserted into and expressed from the SeV genome [9^11]. In
this study, we investigated how far SeV can tolerate insertion
of foreign genes in terms of their lengths and found that a
gene up to 3.2 kb can be readily inserted and expressed. This
size accounts for as much as about 1/5 of the original 15 384
bases of the SeV genome. The non-segmented, linear and hel-
ical RNP is capable of growing longer and thereby can ac-
commodate such a long extra gene. However, as insertion of a
gene longer than 3.2 kb was not attempted, our present study
has been unable to de¢ne the upper limit.
Viral replication speed must be inversely correlated with the
entire genome length. This concept has been used to explain
the superiority of the shorter defective interfering viral ge-
nome to the full length wild-type genome. However, this has
not been illustrated experimentally for any virus. Here, we
were able to show for the ¢rst time such a genome size-de-
pendent growth retardation because all products from the
genes inserted happened, most likely, to be neutral for SeV
replication at least in in vitro cells. Probably because of much
more complex conditions existing in vivo, the principle could
not be very clearly seen in mice but still appeared to be appli-
cable. The fact that recombinant viruses were signi¢cantly
attenuated as long as the inserted gene was su⁄ciently long
suggests the utility of an even replication competent SeV vec-
tor in terms of safety.
Despite the error-prone nature of RNA polymerase in gen-
eral, maintenance of inserted genes was satisfactory [9]. SeV
transcription undergoes polar attenuation toward the 5P end
of thegenome, because the re-initiation at the restart signals of
the downstream genes is e⁄cient but not perfect. Conse-
quently, the highest level of foreign gene expression is ex-
pected when the gene is placed in the ¢rst locus [9]. Further-
more, because of the augmented gene expression of the SeV
V(3) mutant (see above), the use of the V(3) version and
insertion of a gene upstream of its N ORF guaranteed an
extremely high level of expression as shown typically here
for L-gal and previously for HIV-1 gp120. The V(3)-based
expression level of the latter was the highest currently avail-
able in mammalian cells [10]. SeV reaches quite a high copy
number in infected cells, is only moderately cytopathic and
possesses a broad cellular host range. Hence, replication com-
petent SeV vector, particularly the V(3) version, is extremely
useful in producing large quantities of medically important
proteins in cells of interest, thereby greatly contributing to
functional and structural studies (reviewed in [3]).
Large DNA viruses such as VV have most often been used
for production of proteins of interest in mammalian cells.
Because of their large genome sizes, e.g. about 190 kb for
VV, it has been di⁄cult to create a unique restriction site.
Therefore, the step of homologous recombination is necessary
for foreign gene insertion. In contrast, because of its short
size, a unique NotI site has been created in SeV cDNA.
This has greatly facilitated insertion of foreign genes in a
cassette-like fashion.
The viral vectors most frequently used for gene therapy
have derived from retro- and adenoviruses. With the excep-
tion of lentiviruses, retroviruses cannot infect non-dividing
cells and adenoviruses hardly infect cells of blood origin.
Our recombinant SeVs can infect non-dividing cells such as
neurons and replicate there and express foreign genes vigo-
rously (in preparation). They also replicate and express for-
eign genes in the primary human peripheral mononuclear cells
and macrophages in culture [10]. SeV replication is independ-
ent of nuclear functions and does not have a DNA phase.
Thus, it does not transform cells by integrating its genetic
information into the cellular genome. Furthermore, homolo-
gous recombination has not been observed. Thus, replication
incompetent viral constructs grown in complementing cells
should be free of a contaminating virus generated by a recom-
bination event. These properties weigh heavily in favor of SeV
and related non-segmented negative strand RNA viruses in
terms of both utility and safety (reviewed in [3]). Therefore,
vectors of the second generation are awaited, which will no
longer be replication competent but replication incompetent.
They will not encode endogenous envelope proteins but in-
stead incorporate them expressed in trans or are pseudotyped
with foreign viral envelope proteins.
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